Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT02115659 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: Triptolide-Containing Formulation
DRUG: Placebo

Sponsor

Shanghai Changzheng Hospital